BioSpace News Archive

On April 22, Neuboron Medical Group, a leading global Accelerator-based Boron Neutron Capture Therapy total solution provider, and Xiamen Humanity Hospital collaborated to co-host the Xiamen BNCT Technology Forum 2023 at the BNCT center in XHH.

Engitix Ltd announces the appointment of Sonia Quaratino, M.D., PH.D., to its Board of Directors, as an independent non-executive director.

PUR Biologics, an innovative biotech company, and wholly-owned subsidiary of HippoFi, Inc. (OTC PINK:ORHB), today has unveiled its latest product, PURbonedough™, to further expand its leadership into the burgeoning spine biologics market.

MindBio Therapeutics Corp. is pleased to announce its scientific collaborators have recently published their first Peer Reviewed Paper in Biological Psychiatry, an official journal of Psychiatric Neuroscience and Therapeutics.

Novavax, Inc. announced that its COVID-Influenza Combination, stand-alone influenza and high-dose COVID vaccine candidates all showed a reassuring preliminary safety profile as well as comparable reactogenicity to individual Novavax influenza and COVID vaccine candidates or authorized influenza vaccine comparators.

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced its financial results and operational highlights for the first quarter ended March 31, 2023.

Perrigo Company plc (NYSE: PRGO) (“Perrigo” or the “Company”), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter ended April 1, 2023.

Eli Lilly and Company announced new investigational data for mirikizumab in patients with moderately to severely active ulcerative colitis that further support the efficacy and safety seen in previous pivotal studies.

Lung cancer is the leading cause of cancer deaths in the U.S., and anyone can get this disease.

Eagle Pharmaceuticals, Inc. announced financial results for the three months ended March 31, 2023.